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Abstract
Mechanical ventilation is the most important aspect of supportive care of patients with severe acute
respiratory failure. Most research directed to improving the prognosis of these patients has focused
on improving support of the injured lung. In this report, current knowledge on innovative ways to
manage refractory hypoxemia and ventilation without further damaging the injured lung is briefly
discussed.
Introduction and context
Acute respiratory failure due to severe acute lung injury
(ALI) or the acute respiratory distress syndrome (ARDS)
is one of the most challenging problems of patients in
intensive care units (ICUs). For years, mechanical
ventilation (MV), using conventional mechanical venti-
lators, was the only supportive form of therapy providing
adequate oxygenation and carbon dioxide elimination.
MV provides time for disease-specific therapy to reverse
the cause of failure and for recovery of respiratory
function. The adverse effects of conventional MV are the
direct consequence of pulmonary pressure or volume
changes induced by cyclic mechanical insufflations of
diseased lungs or both. Specifically, high-peak alveolar
pressures, cyclic opening and closing of unstable lung
units, and high concentrations of oxygen can cause lung
injury during MV.
The aim of this short review is to summarize the current
literature on a number of alternative techniques (cur-
rently in use worldwide or under evaluation) to improve
oxygenation and ventilation in ALI/ARDS patients with
refractory hypoxemia. Today, refractory hypoxemia is
rare and is an infrequent cause of death (<10% of ARDS
deaths). There is no standard definition for refractory
hypoxemia in terms of a predetermined arterial partial
pressure of oxygen (PaO2) value under a specific oxygen
concentration (fraction of inspired oxygen, or FiO2) and
applied positive end-expiratory pressure (PEEP) level
during a certain period of time. In most reports, it has
been defined as having a PaO2 of less than 60 mm Hg, an
FiO2 of 0.8-1.0, and a PEEP of greater than 10-20 cm
H2O for more than 12-24 hours. For the purpose of this
article, we did not review current techniques that
improve oxygenation by minimizing oxygen consump-
tion, such as muscle paralysis [1], or that are designed to
open collapsed alveoli early in the course of persistent
ARDS, such as the use of recruitment maneuvers
followed by a decremental PEEP trial [2,3]. A recruitment
maneuver is defined as applying a pressure higher than
that applied during a normal breath either intermittently
(for 2-3 minutes) or sustained for a short period of time
(up to about 40 seconds). In a recent meta-analysis [4] of
seven clinical trials involving 1170 patients with ALI/
ARDS, there was no significant difference in survival
between groups receiving an ‘open-lung’ ventilatory
strategy that included recruitment maneuvers and groups
given standard ventilatory care. However, the main
limitation of that systematic review was the design of
trials that either did not isolate recruitment maneuvers
fromothervariablesorassessedonlyshort-termoutcomes,
and few of these trials determined the patient-specific
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mentmaneuvers,a key tothe successful use ofrecruitment
maneuvers.
Recent advances
Extracorporeal membrane oxygenation
This technique was originally applied in patients with
acute respiratory failure of such severity that it was
impossible to provide adequate oxygenation by conven-
tional MV [5]. To supplement gas exchange, a portion of
the cardiac output must go through the extracorporeal
membrane oxygenation (ECMO) circuit. During ECMO,
carbon dioxide is removed by the extracorporeal circuit,
but this technique is usually supplemented with
conventional MV at low ventilatory rates and high
PEEP levels and with tidal volumes to maintain a plateau
pressure of below 28 cm H2O. Most long-term adult
ECMO [6] is performed using the venovenous approach.
Access for both blood removal and return is via
the femoral, saphenous, or jugular veins. Despite the
excitement generated by earlier reports of success, the
results of ECMO trials led to a loss of enthusiasm for its
use in acute respiratory failure. However, some investi-
gators believe that there exists a role for ECMO in young
adult patients with single organ system failure who are
deemed to have potentially reversible pulmonary dys-
function when all other conventional modalities have
failed [7].
Recently, a large muticenter adult ECMO trial was
completed. Referred to as the CESAR trial (Conventional
ventilatory support versus Extracorporeal membrane
oxygenation for Severe Adult Respiratory failure) [8],
this randomized controlled trial (RCT) assessed the
effectiveness of extracorporeal lung assist in 180 patients
with severe ARDS. The results of this study [9] represent
the first positive RCT on adult ECMO application in
severe respiratory failure. Survival at 6 months or
absence of severe disability was achieved in 63% of the
ECMO patients compared with 47% of the control group
(P = 0.03). However, there are a number of major
concerns and limitations with this study. First, patients
allocated to conventional management (control group)
were treated with conventional MV or with high-
frequency ventilation. Second, patients in the control
group were ventilated with a nonstandardized protocol;
to ensure the collaboration of participating centers,
physicians were allowed to choose any ventilatory
strategy. Third, 30% of patients in the control group
were not ventilated with a lung-protective strategy.
Fourth, no data regarding ventilatory parameters at
study entry and during the MV period are presented.
Fifth, all ECMO patients were treated in the same center.
Sixth, the ECMO center did not treat patients randomly
assigned to the conventional management group.
Seventh, many patients randomly assigned to ECMO
did not receive ECMO. In fact, 103 patients who were
screened for eligibility were excluded because a bed was
unavailable forECMOand22patients (25%)assignedto
be transferred to the ECMO center never received ECMO
(16 improved with conventional management). Finally,
a more critical analysis of outcome data when comparing
overall patients who actually received ECMO (68 out of
90) with those who were treated with MV and had
information about mortality (87 plus 22) showed that
the mortality rates were similar in the two groups (48.5%
for ECMO versus 43.1% for MV) (P = 0.64, calculated by
JV and RMK). In addition, the ICU and hospital lengths
of stay were more than double in the ECMO group.
High-frequency oscillatory ventilation
Our understanding of the mechanisms and importance
of ventilator-induced lung injury has advanced over the
last three decades. High-frequency oscillatory ventilation
(HFOV) should theoretically be an ideal mode to
ventilate patients with severe lung damage [10]. It
achieves gas exchange by delivering very small tidal
volumes (often less than the anatomic dead space) at
frequencies ranging from 3 to 15 Hz around a relatively
constant mean airway pressure. HFOV is not a difficult
technique. In fact, it is easier than conventional MV: it
incorporates fewer and simpler controls and they are not
interrelated as they are in conventional mechanical
ventilators. Recent prospective observational studies
have reported that HFOV is a feasible and efficient
method of ventilation that results in rapid and sustained
improvement in oxygenation in patients with severe
ARDS [11-14]. However, a critical examination of RCTs
comparing HFOV with conventional ventilation demon-
strates that there is equivalence between conventional
ventilation and HFOV [15,16]. Specifically, there is no
evidence that conventional MV with low tidal volumes,
high PEEP, and limited plateau pressures is more
harmful than HFOV. All of the RCTs to date have
compared HFOV with a less-than-optimal approach to
conventional ventilation [15]. However, there are at least
two trials that are just beginning that promise to
compare HFOV with more appropriately applied con-
ventional ventilation.
Prone positioning
Changes in posture can have profound effects on the
pulmonary function of patients with severe respiratory
failure. Most changes in pulmonary physiology with
posture occur due to the influence of gravity and chest
wall shape on the mechanical properties of the lung. By
tradition, patients with respiratory failure are cared for in
a supine position. In critically ill patients, the supine
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residual capacity (FRC) below the closing capacity,
resulting in ventilation-perfusion mismatching and a
drop in PaO2. During acute respiratory failure, a
reduction of FRC results in supine hypoxemia regardless
of age. The proposed mechanisms by which prone
positioning improves oxygenation include an increase in
FRC, a change in regional diaphragm motion, redistribu-
tion of perfusion to better ventilated lung units,
redistribution of ventilation to better perfused lung
units, and improved secretion clearance [17].
The act of turning is labor-intensive; at least three
experienced staff members are required in order to
avoid losing vascular accesses or the airway. Meticulous
care must be used in positioning the patient. Placing a
neck roll or a pillow under the patient’s shoulders and
turning the head to one side is the recommended way to
support the patient when prone. In addition, prone
positioning may require an increased need for sedation.
Although complications such as skin injury, facial
edema, catheter removal or compression, hypotension,
arrhythmias, and extubation may occur, prone position-
ing in general can be performed safely if staff are
appropriately trained.
Although there are sufficient data to conclude that
oxygenation frequently improves when patients with
ARDS are turned prone (in about 70% of patients),
prone positioning is still not widely implemented.
Three recent systematic reviews and a meta-analysis
[18-20] in patients with ALI/ARDS have shown that
prone positioning does not reduce mortality or duration
of MV despite improved oxygenation and a decreased
risk of pneumonia.
Inhaled vasodilators
Anti-inflammatory agents and vasodilators have been
tried experimentally in animals and humans as prophy-
laxis or treatment of ARDS. Prostaglandins, ibuprofen,
pentoxifylline, inhaled nitric oxide (iNO), inhaled
prostacyclin, almitrine, and corticosteroids have all
been tried. None of them has shown any major benefit
on outcome in large randomized human trials, even
though significant improvements in oxygenation have
been observed with some of these agents [21].
NO is important for the regulation of pulmonary
vascular smooth muscle. NO appears to be pivotal in
acute and chronic hypoxic pulmonary vasoconstriction.
Pulmonary hypertension is a typical feature of ARDS and
is a bad prognostic factor in respiratory failure. iNO
selectively dilates pulmonary vasculature without sys-
temic effects [22]. Over the last 15 years, an increasing
number of clinical studies assessing different aspects of
iNO in ARDS patients and addressing the ability of NO
to attenuate ALI have been published. In spite of the fact
that many clinicians consider iNO a useful rescue
treatment for ARDS patients, no RCT has demonstrated
an outcome benefit. A recent systematic review and
meta-analysis of 12 RCTs including a total of 1237
patients with severe ALI/ARDS found that, as a whole,
NO is associated with limited improvement in oxygena-
tion at 24 hours of therapy, has no effect on duration of
ventilation, does not confer mortality benefits, and may
cause harm [23].
Implications for clinical practice
As a result of this brief review of recent advances for the
treatment of severe acute hypoxemic respiratory failure,
our interpretation is that (a)there is not enough evidence
to date from well-performed RCTs to routinely recom-
mend the use of ECMO as rescue therapy in adults with
severe ARDS, (b) there is no ventilatory mode (including
HFOV) that has been proven to be superior to limiting
end-inspiratory plateau pressures and tidal volumes and
appropriately setting PEEP, (c) altering body position is
part of the routine clinical care in most patients with
respiratory failure but there is no evidence to support the
routine use of prone positioning, and (d) none of the
pharmacologic therapies evaluated in ALI/ARDS, includ-
ing inhaled vasodilators, has been shown to reduce
morbidity or mortality when compared with placebo or
conventional treatment. The good news is that none of
these therapies that improve oxygenation significantly
increases morbidity or mortality. As a result, when
conventional therapy fails, all can be considered.
However, remember that the only thing they may
accomplish is increasing costs!
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